EMA Authorised: Kaletra (lopinavir;ritonavir) — AbbVie Deutschland GmbH & Co. KG

View source ↗

Summary

The European Medicines Agency authorised Kaletra (lopinavir/ritonavir) for HIV infections, with AbbVie Deutschland GmbH & Co. KG as the marketing authorisation …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: AbbVie Deutschland GmbH & Co. KG. Decision date: 30/10/2025